TD Cowen Maintains Buy on DexCom, Raises Price Target to $95
Benzinga Newsdesk 5 months ago
NewsPrice TargetAnalyst Ratings
TD Cowen analyst Joshua Jennings maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $75 to $95.
TD Cowen analyst Joshua Jennings maintains DexCom (NASDAQ:DXCM) with a Buy and raises the price target from $75 to $95.